Back to Investors
CG

Crista Galli Ventures

Venture Capital

Portfolio

4

companies


Portfolio companies

VH

Vitrue Health

Digital musculoskeletal health platform for workplace ergonomic assessments and injury prevention.

CB

CardiaTec Biosciences

CardiaTec Biosciences applies artificial intelligence to multiomic data for cardiovascular drug discovery.

Holly Health

Holly Health

Holly Health provides personalised digital health coaching to help people manage chronic conditions.

S

Sanome

Sanome develops an engine for clinically validated home testing diagnostics.


Team

FP

Fiona Pathiraja

founder


Recent investments

Seed
£3.2M

MMC Ventures and Hambro Perks led the round to support team growth and international expansion.

"Musculoskeletal health conditions have been a societal problem across the world for decades, and our data shows that rates of pain have massively increased since the rise of hybrid working. With this new funding, we’ll be able to continue our growth to reduce the financial and health costs for employers and their teams."
— Shane Lowe, Co-Founder and CEO
Pre-Seed
£1.4M

The pre-seed round was co-led by Laidlaw Scholars Ventures and APEX Ventures.

"Recent advances in artificial intelligence are generating novel ways to interpret multiomic data. I am excited to lead CardiaTec’s technology strategy to establish a new paradigm for understanding the pathophysiology of cardiovascular diseases."
— Namshik Han, CTO
Seed
£1.4M

The financing round includes backing from Kima Ventures alongside a UKRI award to adapt the digital health coach for older adults.

"Age UK Lewisham and Southwark exists to improve the lives of older people, working towards a future in which all people are valued, safe, and empowered to make choices about their lives."
— Ross Diamond
Pre-Seed
£2.0M

The funding round was led by Heal Capital and will support team expansion and product development.

"Healthcare touches each and every one of us and the recent pandemic has highlighted that at a global level. It showed the need to bring healthcare closer to people’s homes and that we need to leverage many of the recent innovations in digital health and consumer biotech to capture as many data points about human health as possible. This will transform our understanding of the human body and our approach to disease detection and management. At Sanome we are working toward developing multiple at home health tools to drive disruption within the healthcare landscape to benefit each one of us"
— Benedikt von Thüngen, CEO